Legal Representation
Attorney
Patrick J. Jennings
USPTO Deadlines
Next Deadline
1962 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-26)
Due Date
November 26, 2030
Grace Period Ends
May 26, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
10 eventsDate | Code | Type | Description |
---|---|---|---|
Nov 26, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Nov 26, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Sep 18, 2024 | ISCR | Z | WITHDRAWN FROM ISSUE - OG REVIEW QUERY |
Jul 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jul 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jun 19, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
May 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
May 30, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 22, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jan 22, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Testing of pharmaceuticals; Medical and scientific research in the field of protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, benign prostatic hyperplasia, and prostate cancer
First Use Anywhere:
20070500
First Use in Commerce:
20070500
Classification
International Classes
042
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO